Top 100 Contractors in PSC 6550: In Vitro Diagnostic Substances, Reagents, Test Kits and Sets, Aug 2025–Jul 2026

Parent companies by net contract obligations Aug 1, 2025 – Jul 31, 2026 Code page on GovTribe

The latest 12 months. See the newest fiscal year's list: Top Contractors in PSC 6550: In Vitro Diagnostic Substances, Reagents, Test Kits and Sets, FY2025.

The top 10 won 56% of PSC 6550 contract dollars from August 2025 through July 2026

Ranking facts

Contract obligations
$201,280,572 Net of deobligations, by contracts coded PSC 6550
Contractors
184 Parent companies with an obligation
Largest contractor
Danaher Corporation $45.3 million, 18.1% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV · Free to reuse with credit to GovTribe (CC BY 4.0)

Full ranking

Rank Contractor Net obligations Share Trend
1 $45,258,183
Rank history: #3 in FY2021, #5 in FY2022, #6 in FY2023, #1 in FY2024 and #1 in FY2025; unchanged since Aug 2024–Jul 2025.
2 $25,139,509
Rank history: #70 in FY2021, not on the FY2022–FY2023 lists, #5 in FY2024 and #10 in FY2025; new, not ranked in Aug 2024–Jul 2025.
3 $22,762,650
Rank history: not on the FY2021–FY2023 lists, #22 in FY2024 and #2 in FY2025; up 1 since Aug 2024–Jul 2025.
4 $11,079,678
Rank history: #2 in FY2021, #2 in FY2022, #1 in FY2023, #7 in FY2024 and #4 in FY2025; up 2 since Aug 2024–Jul 2025.
5 $7,990,243
Rank history: not on the FY2021–FY2023 lists, #12 in FY2024 and #6 in FY2025; up 4 since Aug 2024–Jul 2025.
6 $7,218,404
Rank history: not on the FY2021–FY2022 lists, #48 in FY2023, #10 in FY2024 and #11 in FY2025; up 6 since Aug 2024–Jul 2025.
7 $6,824,061
Rank history: #4 in FY2021, #55 in FY2022, not on the FY2023 list, #17 in FY2024 and #5 in FY2025; unchanged since Aug 2024–Jul 2025.
8 $5,225,670
Rank history: #15 in FY2021, #16 in FY2022, #15 in FY2023, #11 in FY2024 and #7 in FY2025; up 2 since Aug 2024–Jul 2025.
9 $4,890,080
Rank history: #12 in FY2021, #11 in FY2022, #12 in FY2023, #9 in FY2024 and #12 in FY2025; up 27 since Aug 2024–Jul 2025.
10 $4,749,474
Rank history: #70 in FY2021, not on the FY2022–FY2023 lists, #5 in FY2024 and #3 in FY2025; down 7 since Aug 2024–Jul 2025.
11 $4,216,437
Rank history: not on the FY2021–FY2023 lists, #19 in FY2024 and #8 in FY2025; down 3 since Aug 2024–Jul 2025.
12 $4,010,929
Rank history: #37 in FY2021, #27 in FY2022, #21 in FY2023, #31 in FY2024 and #9 in FY2025; up 5 since Aug 2024–Jul 2025.
13 $4,004,438
Rank history: #13 in FY2021, #13 in FY2022, #14 in FY2023, #13 in FY2024 and #13 in FY2025; unchanged since Aug 2024–Jul 2025.
14 $3,728,920
Rank history: #16 in FY2021, #18 in FY2022, #24 in FY2023, #18 in FY2024 and #14 in FY2025; up 2 since Aug 2024–Jul 2025.
15 $3,330,499
Rank history: not on the FY2021–FY2023 lists, #77 in FY2024 and #53 in FY2025; up 39 since Aug 2024–Jul 2025.
16 $3,005,901
Rank history: not on the FY2021–FY2024 lists and #18 in FY2025; up 9 since Aug 2024–Jul 2025.
17 $2,291,752
Rank history: not on the FY2021–FY2023 lists, #60 in FY2024 and #17 in FY2025; up 5 since Aug 2024–Jul 2025.
18 $2,253,766
Rank history: #40 in FY2021, #52 in FY2022, #36 in FY2023, #34 in FY2024 and #16 in FY2025; up 1 since Aug 2024–Jul 2025.
19 $2,092,907
Rank history: not on the FY2021 list, #26 in FY2022 and not on the FY2023–FY2025 lists; up 30 since Aug 2024–Jul 2025.
20 $1,952,614
Rank history: not on the FY2021–FY2023 lists, #23 in FY2024 and #21 in FY2025; up 3 since Aug 2024–Jul 2025.
21 $1,636,070
Rank history: #7 in FY2021, #3 in FY2022, #18 in FY2023, #28 in FY2024 and not on the FY2025 list; new, not ranked in Aug 2024–Jul 2025.
22
Novartis Pharmaceuticals Corporation
$1,483,015
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
23 $1,349,205
Rank history: #26 in FY2021, #47 in FY2022, #39 in FY2023, #30 in FY2024 and #20 in FY2025; down 2 since Aug 2024–Jul 2025.
24 $1,308,045
Rank history: #30 in FY2021, #29 in FY2022, #34 in FY2023, #26 in FY2024 and #31 in FY2025; up 6 since Aug 2024–Jul 2025.
25 $1,293,644
Rank history: not on the FY2021–FY2024 lists and #44 in FY2025; up 45 since Aug 2024–Jul 2025.
26 $1,246,969
Rank history: not on the FY2021–FY2024 lists and #58 in FY2025; up 37 since Aug 2024–Jul 2025.
27 $1,200,542
Rank history: #24 in FY2021, #28 in FY2022, #37 in FY2023, #42 in FY2024 and #28 in FY2025; up 4 since Aug 2024–Jul 2025.
28 $1,052,683
Rank history: not on the FY2021–FY2024 lists and #25 in FY2025; up 1 since Aug 2024–Jul 2025.
29 $1,008,866
Rank history: not on the FY2021–FY2023 lists, #36 in FY2024 and #26 in FY2025; down 1 since Aug 2024–Jul 2025.
30 $915,302
Rank history: #36 in FY2021, #39 in FY2022, #31 in FY2023, #43 in FY2024 and #23 in FY2025; down 4 since Aug 2024–Jul 2025.
31 $823,142
Rank history: #33 in FY2021, #42 in FY2022, #49 in FY2023, #45 in FY2024 and #38 in FY2025; up 8 since Aug 2024–Jul 2025.
32 $721,744
Rank history: #89 in FY2021, not on the FY2022 list, #75 in FY2023, #29 in FY2024 and #33 in FY2025; up 5 since Aug 2024–Jul 2025.
33 $703,298
Rank history: not on the FY2021–FY2023 lists, #51 in FY2024 and #34 in FY2025; up 13 since Aug 2024–Jul 2025.
34 $607,034
Rank history: not on the FY2021–FY2024 lists and #24 in FY2025; down 7 since Aug 2024–Jul 2025.
35 $595,000
Rank history: #34 in FY2021, #37 in FY2022, #30 in FY2023, #62 in FY2024 and #35 in FY2025; up 6 since Aug 2024–Jul 2025.
36 $584,819
Rank history: #18 in FY2021, #22 in FY2022, #26 in FY2023, #55 in FY2024 and #39 in FY2025; up 8 since Aug 2024–Jul 2025.
37 $566,909
Rank history: not on the FY2021 list, #61 in FY2022, #45 in FY2023, #40 in FY2024 and #40 in FY2025; up 3 since Aug 2024–Jul 2025.
38 $538,136
Rank history: not on the FY2021–FY2024 lists and #19 in FY2025; new, not ranked in Aug 2024–Jul 2025.
39 $535,558
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
40 $524,777
Rank history: #44 in FY2021, #43 in FY2022, #65 in FY2023, #72 in FY2024 and #54 in FY2025; up 10 since Aug 2024–Jul 2025.
41
Grifols Diagnostic Solutions Inc.
$523,741
Rank history: not on the FY2021–FY2023 lists, #69 in FY2024 and #32 in FY2025; down 6 since Aug 2024–Jul 2025.
42 $518,063
Rank history: not on the FY2021–FY2024 lists and #47 in FY2025; up 61 since Aug 2024–Jul 2025.
43 $466,549
Rank history: #80 in FY2021, #85 in FY2022, not on the FY2023–FY2024 lists and #37 in FY2025; up 8 since Aug 2024–Jul 2025.
44 $403,654
Rank history: not on the FY2021–FY2024 lists and #22 in FY2025; down 20 since Aug 2024–Jul 2025.
45 $402,766
Rank history: #23 in FY2021, #20 in FY2022, #51 in FY2023, #35 in FY2024 and #29 in FY2025; down 2 since Aug 2024–Jul 2025.
46 $395,823
Rank history: not on the FY2021 list, #45 in FY2022, not on the FY2023–FY2024 lists and #63 in FY2025; up 49 since Aug 2024–Jul 2025.
47 $392,088
Rank history: #66 in FY2021, #78 in FY2022, #76 in FY2023, #56 in FY2024 and not on the FY2025 list; up 10 since Aug 2024–Jul 2025.
48 $390,845
Rank history: not on the FY2021–FY2024 lists and #42 in FY2025; down 3 since Aug 2024–Jul 2025.
49 $373,401
Rank history: #71 in FY2021, #38 in FY2022, #70 in FY2023, #59 in FY2024 and #45 in FY2025; up 4 since Aug 2024–Jul 2025.
50 $349,693
Rank history: #41 in FY2021, #50 in FY2022, #55 in FY2023, #57 in FY2024 and #41 in FY2025; down 3 since Aug 2024–Jul 2025.
51 $347,507
Rank history: not on the FY2021–FY2024 lists and #62 in FY2025; up 27 since Aug 2024–Jul 2025.
52 $326,807
Rank history: #35 in FY2021, #46 in FY2022, #59 in FY2023, #52 in FY2024 and #43 in FY2025; down 4 since Aug 2024–Jul 2025.
53 $292,973
Rank history: #83 in FY2021, not on the FY2022 list, #27 in FY2023, #38 in FY2024 and #55 in FY2025; new, not ranked in Aug 2024–Jul 2025.
54
Fresenius Medical Care Holdings Inc. Through Fenwal, Inc.
$286,074
Rank history: not on the FY2021–FY2025 lists; up 63 since Aug 2024–Jul 2025.
55 $283,481
Rank history: not on the FY2021–FY2024 lists and #50 in FY2025; new, not ranked in Aug 2024–Jul 2025.
56
RLS (USA) Inc.
$250,075
Rank history: not on the FY2021–FY2024 lists and #46 in FY2025; down 1 since Aug 2024–Jul 2025.
57 $248,906
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
58 $246,510
Rank history: not on the FY2021 list, #81 in FY2022, #81 in FY2023, #94 in FY2024 and #60 in FY2025; up 9 since Aug 2024–Jul 2025.
59
Cambridge Isotope Laboratories Inc.
$221,095
Rank history: not on the FY2021–FY2024 lists and #61 in FY2025; up 129 since Aug 2024–Jul 2025.
60 $216,015
Rank history: #45 in FY2021, #53 in FY2022, #72 in FY2023, #49 in FY2024 and #30 in FY2025; down 27 since Aug 2024–Jul 2025.
61 $210,558
Rank history: #64 in FY2021, #82 in FY2022, #71 in FY2023, #80 in FY2024 and #68 in FY2025; up 15 since Aug 2024–Jul 2025.
62 $200,895
Rank history: not on the FY2021–FY2024 lists and #86 in FY2025; up 23 since Aug 2024–Jul 2025.
63 $188,660
Rank history: not on the FY2021 list, #10 in FY2022, #8 in FY2023, #84 in FY2024 and #59 in FY2025; up 18 since Aug 2024–Jul 2025.
64 $184,738
Rank history: not on the FY2021 list, #71 in FY2022, #60 in FY2023, #79 in FY2024 and #74 in FY2025; up 24 since Aug 2024–Jul 2025.
65 $172,740
Rank history: #77 in FY2021, #30 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
66 $155,227
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
67 $155,000
Rank history: not on the FY2021–FY2022 lists, #22 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
68 $151,845
Rank history: not on the FY2021–FY2022 lists, #94 in FY2023, not on the FY2024 list and #48 in FY2025; down 6 since Aug 2024–Jul 2025.
69 $148,968
Rank history: not on the FY2021–FY2024 lists and #81 in FY2025; up 21 since Aug 2024–Jul 2025.
70 $146,995
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
71 $146,500
Rank history: not on the FY2021–FY2024 lists and #75 in FY2025; new, not ranked in Aug 2024–Jul 2025.
72 $142,777
Rank history: not on the FY2021–FY2022 lists, #33 in FY2023, not on the FY2024 list and #69 in FY2025; down 11 since Aug 2024–Jul 2025.
73 $135,240
Rank history: not on the FY2021–FY2023 lists, #96 in FY2024 and #82 in FY2025; up 18 since Aug 2024–Jul 2025.
74 $129,000
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
75 $128,917
Rank history: not on the FY2021–FY2023 lists, #86 in FY2024 and #87 in FY2025; up 12 since Aug 2024–Jul 2025.
76 $124,750
Rank history: not on the FY2021–FY2024 lists and #72 in FY2025; up 86 since Aug 2024–Jul 2025.
77
Sysmex Deutschland GMBH
$120,115
Rank history: #19 in FY2021, #14 in FY2022, #13 in FY2023, #14 in FY2024 and not on the FY2025 list; up 47 since Aug 2024–Jul 2025.
78 $118,170
Rank history: not on the FY2021–FY2023 lists, #65 in FY2024 and #99 in FY2025; up 33 since Aug 2024–Jul 2025.
79 $116,573
Rank history: not on the FY2021–FY2024 lists and #76 in FY2025; up 10 since Aug 2024–Jul 2025.
80 $112,137
Rank history: #50 in FY2021, not on the FY2022–FY2024 lists and #85 in FY2025; new, not ranked in Aug 2024–Jul 2025.
81 $111,196
Rank history: #93 in FY2021, not on the FY2022 list, #96 in FY2023, not on the FY2024 list and #77 in FY2025; down 2 since Aug 2024–Jul 2025.
82
Biocartis US Inc
$108,922
Rank history: not on the FY2021–FY2025 lists; up 30 since Aug 2024–Jul 2025.
83 $106,888
Rank history: not on the FY2021–FY2024 lists and #89 in FY2025; up 50 since Aug 2024–Jul 2025.
84 $103,360
Rank history: not on the FY2021–FY2025 lists; up 16 since Aug 2024–Jul 2025.
85 $102,402
Rank history: not on the FY2021–FY2024 lists and #95 in FY2025; up 20 since Aug 2024–Jul 2025.
86
Nikon Metrology Inc Through Nikon Instruments Inc.
$100,580
Rank history: not on the FY2021–FY2024 lists and #93 in FY2025; new, not ranked in Aug 2024–Jul 2025.
87 $96,268
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
88 $91,425
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
89 $91,250
Rank history: not on the FY2021–FY2024 lists and #70 in FY2025; up 10 since Aug 2024–Jul 2025.
90 $90,789
Rank history: not on the FY2021 list, #76 in FY2022, not on the FY2023 list, #98 in FY2024 and #98 in FY2025; up 26 since Aug 2024–Jul 2025.
91 $85,865
Rank history: not on the FY2021–FY2022 lists, #97 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
92 $84,079
Rank history: not on the FY2021 list, #90 in FY2022, #89 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
93 $82,300
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
94 $81,803
Rank history: not on the FY2021–FY2024 lists and #100 in FY2025; up 19 since Aug 2024–Jul 2025.
95
Laboratory Corporation of America 3 awardees
$73,400
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
96 $66,890
Rank history: not on the FY2021–FY2025 lists; up 23 since Aug 2024–Jul 2025.
97 $65,599
Rank history: #20 in FY2021, #17 in FY2022, #16 in FY2023, #8 in FY2024 and not on the FY2025 list; up 38 since Aug 2024–Jul 2025.
98 $65,283
Rank history: not on the FY2021–FY2025 lists; up 40 since Aug 2024–Jul 2025.
99 $65,112
Rank history: not on the FY2021–FY2024 lists and #79 in FY2025; up 9 since Aug 2024–Jul 2025.
100 $64,400
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
Show 75 more

100 of 184 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $250 million obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. An awardee whose own actions mostly name no parent, and that no other company's actions name as their parent, rolls up its SAM.gov registration's chain of parent companies: it counts under the first company there that other companies' actions name as their parent, or under the parent most of a company's own actions name, whichever comes first; with neither, under the highest company in the chain with federal contracts of its own. Joint ventures stay companies of their own. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Period: the trailing 12 months end with the last month that ended at least 90 days ago, because the Department of Defense reports its contract actions to FPDS about 90 days late. The list is rebuilt each night.
  • Rank changes compare with Aug 2024–Jul 2025. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 PSC 6550 contractors in Aug 2025–Jul 2026?

1. Danaher Corporation ($45.3M), 2. Biomerieux Inc. ($25.1M), 3. Roche Holdings Inc. ($22.8M), 4. Abbott Laboratories Inc. ($11.1M), 5. Sysmex America Inc. ($7.99M), 6. Thermo Fisher Scientific Inc. ($7.22M), 7. Ortho-Clinical Diagnostics Inc. ($6.82M), 8. Illumina, Inc. ($5.23M), 9. Hologic, Inc. ($4.89M), 10. Biofire Defense LLC ($4.75M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work